COMP <GO>
NPCE vs SSII // PIOTROSKI F-SCORE QUALITY
Neuropace Inc. (NASDAQ) VS. SS Innovations International Inc. (NASDAQ) • 15-METRIC TALLY: NPCE 6
— SSII 4
▲ PIOTROSKI F-SCORE QUALITY LEADER: NPCE
LAST: $13.01 (+0.62%) • MKT CAP: $446.6M
piotroski-score
5/9
LAST: $2.38 (-2.46%) • MKT CAP: $477.2M
piotroski-score
4/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NPCE VS. SSII)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NPCE | SSII | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 77.20% | 46.00% | +31.20 | NPCE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -23.00% | -18.50% | -4.50 | SSII | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -2.54% | -4.65% | +2.11 | NPCE | /fcf-yield <GO> |
| Operating Margin | -16.30% | -19.30% | +3.00 | NPCE | /operating-margins <GO> |
| Net Profit Margin | -21.50% | -28.50% | +7.00 | NPCE | /net-margins <GO> |
| Revenue Growth (YoY) | 25.10% | 105.70% | -80.60 | SSII | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 7.47 | -7.27 | SSII | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 5/9 | 4/9 | +1.00 | NPCE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 39.3 | 35.9 | +3.40 | NPCE | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $446.6M | $477.2M | -$30.6M | SSII | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NPCE REV | SSII REV | NPCE GROSS % | SSII GROSS % | NPCE FCF | SSII FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $100.0M | $42.5M | 77.2% | 46.0% | -$11.3M | -$22.2M |
| FY 2024 | $79.9M | $20.6M | 73.9% | 40.9% | -$18.3M | -$10.2M |
| FY 2023 | $65.4M | $5.9M | — | — | -$19.7M | -$15.4M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NPCE // BETA —
SSII // BETA —